Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RH Bophelo's Other Operating Expense for the
six
months ended in Feb. 2026 was R11.60 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 was R22.61 Mil.
RH Bophelo's quarterly Other Operating Expense
declined
from Feb. 2025 (R16.36 Mil) to Aug. 2025 (R11.01 Mil) but then
increased
from Aug. 2025 (R11.01 Mil) to Feb. 2026 (R11.60 Mil).
RH Bophelo's annual Other Operating Expense
increased
from Feb. 2024 (R25.33 Mil) to Feb. 2025 (R32.36 Mil) but then
declined
from Feb. 2025 (R32.36 Mil) to Feb. 2026 (R22.61 Mil).
RH Bophelo Other Operating Expense Historical Data
* Premium members only.
The historical data trend for RH Bophelo's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R22.61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of R22.61 Mil mean?
RH Bophelo (JSE:RHB) has a Other Operating Expense of R22.61 Mil as of Feb. 2026. Other operating expenses that a company records on its income statement. View historical data on RH Bophelo and its competitors.
Is RH Bophelo's Other Operating Expense too high?
RH Bophelo's current Other Operating Expense is R22.61 Mil. Overall, RH Bophelo has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RH Bophelo's Other Operating Expense compare to BLK and BX?
RH Bophelo's Other Operating Expense of R22.61 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for an Asset Management company?
A good Other Operating Expense depends on the Asset Management industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on RH Bophelo and its competitors. RH Bophelo's current Other Operating Expense is R22.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RH Bophelo stock overvalued right now?
Based on GuruFocus' analysis, RH Bophelo (JSE:RHB) is currently considered Possible Value Trap. The stock's GF Value™ is R6.26, compared to a current price of R2.00 — trading 68.1% below its estimated fair value. The current Other Operating Expense is R22.61 Mil. RH Bophelo's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For RH Bophelo (JSE:RHB), the current Other Operating Expense is R22.61 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RH Bophelo (JSE:RHB) Overvalued in 2026?
Based on GuruFocus' analysis, RH Bophelo stock appears to be undervalued.
The current stock price of R2.00 is trading 68.1% below its estimated GF Value™ of R6.26.
GuruFocus considers RH Bophelo to be Possible Value Trap.
Key valuation signals for JSE:RHB:
Other Operating Expense: R22.61 Mil
GF Value™: R6.26 vs. price of R2.00 (68.1% below fair value)
No single metric tells the full story. See the JSE:RHB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RH Bophelo Ltd is a healthcare investment company. Its main business involves the acquisition of healthcare assets in commercial entities or special situations across the South African market. It is engaged in making equity, quasi-equity, and equity-related investments in healthcare and financial sectors, specifically in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company's operating segments are the Healthcare segment and the Financial Services segment. The majority of its revenue is generated from the Healthcare segment, which focuses on making investments in healthcare infrastructure, healthcare technology, and property companies.
74GF Score
Get the complete analysis for JSE:RHB
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:RHB has been successfully added to your 
